Amarantus BioSciences to Present at the National Investment Banking Association's (NIBA)122nd Conference in New York …

Posted: Published on June 7th, 2012

This post was added by Dr Simmons

SUNNYVALE, Calif., June 6, 2012 /PRNewswire/ --Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing drug and diagnostic products for the treatment of Parkinson's disease and other nervous system disorders including Traumatic Brain Injury, today announced that it has been selected to participate in the National Investment Banking Association's 122nd Conference in New York City at Le Park Meridien Hotel June 7-8, 2012. Mr. Gerald Commissiong, Amarantus' President & CEO, will be a featured presenter.

"We are excited to present Amarantus to the investment community in New York City over the next few days at the NIBA event," said Gerald E. Commissiong, President & CEO of Amarantus. "This conference will allow Amarantus to engage with small-cap and micro-cap investors who can understand the tremendous value proposition that our Company represents. Amarantus is striving to become the leader in the development of new drug and diagnostic products for the brain. Our flagship MANF Program is a potential blockbuster opportunity."

NIBA is a national not-for-profit trade association of regional and independent brokerages, investment banking firms, institutional investors and related capital market service providers. Since its inception, NIBA member firms have successfully completed over 1000 equity offerings totaling approximately $10 billion in new capital for America's finest emerging growth companies. The member firms of NIBA represent over 8000 registered representatives with an estimated $78 billion in assets under management, and are responsible for 90% of all Initial Public Offerings under $20 million.

PRESENTATIONINFORMATION AT A GLANCE:

WHO:

Gerald Commissiong, President and Chief Executive Officer

WHEN:

June 7th, 2012 at 3pm ET in the Azekka Banquet Room

Go here to see the original:
Amarantus BioSciences to Present at the National Investment Banking Association's (NIBA)122nd Conference in New York ...

Related Posts
This entry was posted in Brain Injury Treatment. Bookmark the permalink.

Comments are closed.